Risk And Supply Chain Continuity Management Biologics Industry Perspectives

A conversation with Melinda McCants, Andrew Goldman, and Sonia Schwantes, members of BioPhorum

We spoke to three long-standing members of BioPhorum’s Risk and Business Continuity Workstream about their companies’ approaches to risk management and what they learned from the pandemic. They are Melinda McCants, senior resiliency officer at Amgen; Andrew Goldman, head of business continuity and supply chain risk at Merck KGaA; and Sonia Schwantes, director of product management at New Age Industries.

How Did You Manage Risk And Business Continuity Before COVID-19?

“After the earthquakes and tsunami in Japan in 2011, we put a huge effort into understanding our supply base and building a risk management program,” said Melinda McCants. “But when I started in 2017, I realized that while we had a good tool on paper, we didn’t have a process for what we would do in a disruption event. So, we documented the steps to follow, mapped our supply chain, and started working with our suppliers to define the actions needed. It meant we were in good shape when Hurricane Maria struck Puerto Rico in September 2017.”

Andrew Goldman…

Актуальные книги на английском